72,234 articles
IBERICAN study
IBERICAN (Identificación de la poBlación Española de RIesgo CArdiovascular y reNal) is a Spanish SEMERGEN prospective primary care cohort of 8,066 adults (2014–2018) tracking cardiovascular and renal risk, CKD, pulse pressure, and heart failure.
Iberis
Iberis, commonly candytuft, is a Mediterranean genus of about 30 species in Brassicaceae, tribe Iberideae, native from western Europe to Iran; I. sempervirens is the familiar evergreen white-flowered ground cover.
Ibex
Ibex, or steinbok and bouquetin, are wild goats of genus Capra, chiefly the Alpine ibex (Capra ibex), saved from extinction at Gran Paradiso and now Least Concern; related species include Siberian, Nubian, Iberian, and Walia ibexes.
IBI3001, EGFR/B7-H3 bispecific antibody-drug conjugate
IBI3001 (IBI-3001) is Innovent Biologics' potentially first-in-class bispecific antibody-drug conjugate targeting B7-H3 (CD276) and EGFR, glycan-conjugated to exatecan at DAR 4, in a Phase 1 solid tumor trial (NCT06349408) with a Takeda ex-China license option.
IBI355 (SP001)
IBI355 (SP001) is Innovent Biologics' third-generation Fc-silent anti-CD40L monoclonal antibody for autoimmune disease, licensed to Spero Therapeutics in 2026 for about $1.1 billion, with Phase 2 trials planned in IgG4-RD and Sjögren's disease.
IBI363, PD-1/IL-2α-bias bispecific fusion protein
IBI363 (TAK-928), Innovent Biologics' first-in-class PD-1/IL-2 alpha-bias bispecific antibody fusion protein, blocks PD-1 and cis-activates IL-2 receptors on exhausted tumor-specific T cells; partnered with Takeda in a US$1.2 billion deal for global development outside Greater China.
Ibis
Ibis, wading birds of the family Threskiornithidae (with spoonbills), known for long down-curved bills used to probe mud for prey; range from Least Concern Black-headed Ibis to Critically Endangered São Tomé ibis.
Ibizan Hound
Ibizan Hound (Podenco Ibicenco, ca eivissenc): a lean, large-eared Spanish sighthound from Ibiza, bred to course rabbits by sight, sound, and scent; AKC-recognized Hound, 22.5–27.5 inches, white or red coat, smooth or wire.
Ibodutant
Ibodutant (MEN15596) is a Menarini nonpeptide tachykinin NK2 receptor antagonist investigated for diarrhea-predominant IBS; effective in women in phase II (IRIS-2) but failed phase III and was never licensed.
Ibogaine
Ibogaine, a psychoactive indole alkaloid from the African shrub Tabernanthe iboga (Bwiti sacrament), is an experimental anti-addiction drug that interrupts opioid withdrawal but causes QTc prolongation, arrhythmias, and deaths; it remains US Schedule I with no completed controlled trial.
Ibrahim Abubakar
Ibrahim Abubakar is a Nigerian-born British infectious disease epidemiologist at University College London, known for tuberculosis research and the UCL–Lancet Commission on Migration and Health.
Ibrexafungerp
Ibrexafungerp (SCY-078, MK-3118; Brexafemme), first-in-class oral triterpenoid antifungal derived from enfumafungin; inhibits 1,3-beta-D-glucan synthase; FDA-approved 2021 for vulvovaginal candidiasis and recurrent RVVC reduction.
Ibritumomab tiuxetan
Ibritumomab tiuxetan (Zevalin) is a murine anti-CD20 antibody linked via tiuxetan to yttrium-90, the first FDA-approved radioconjugated antibody for cancer (2002), treating relapsed or refractory B-cell non-Hodgkin lymphoma; EU authorization lapsed in 2024.
Ibrutinib
Ibrutinib (Imbruvica) is the first-in-class oral covalent Bruton's tyrosine kinase inhibitor, binding C481 irreversibly. Approved by the FDA from November 2013 for CLL/SLL, Waldenström's macroglobulinemia, and cGVHD; MCL and MZL indications withdrawn in 2023.
Ibrutinib plus obinutuzumab
Ibrutinib plus obinutuzumab is a chemotherapy-free combination regimen pairing the oral BTK inhibitor ibrutinib with the anti-CD20 antibody obinutuzumab, FDA approved in 2019 for previously untreated chronic lymphocytic leukemia.
Ibrutinib regimen
The ibrutinib regimen is a combination treatment for primary central nervous system lymphoma in which the BTK inhibitor ibrutinib is given with high-dose methotrexate, usually with rituximab.
Ibrutinib–venetoclax regimen
The ibrutinib–venetoclax regimen is an all-oral, fixed-duration therapy pairing the BTK inhibitor ibrutinib with the BCL-2 inhibitor venetoclax, used mainly for chronic lymphocytic leukemia and authorized in Europe in 2022.
IBSP
IBSP (integrin-binding sialoprotein, bone sialoprotein II) is a human chromosome 4q22.1 gene encoding a SIBLING-family RGD bone matrix glycoprotein involved in mineralization, bone healing, and cancer metastasis.
Ibudilast
Ibudilast (MN-166, AV411, Ketas) is an oral nonselective PDE inhibitor (PDE-3/4/10/11) also inhibiting MIF and TLR-4; approved in Japan since 1989 for asthma and post-stroke dizziness, in trials for progressive MS and ALS.
Ibufenac
Ibufenac (Dytransin, Boots), 4-isobutylphenylacetic acid, an NSAID anti-inflammatory analgesic marketed 1966 for rheumatic disease and withdrawn February 1968 for hepatotoxicity; predecessor of ibuprofen.
Ibuprofen
Ibuprofen (2-(4-isobutylphenyl) propionic acid; brands Brufen, Motrin, Nurofen, Advil) is an NSAID painkiller and fever reducer discovered by Stewart Adams and John Nicholson at Boots, patented 1961, launched 1969.
Ibutamoren
Ibutamoren (MK-677, MK-0677, LUM-201) is an oral non-peptide ghrelin receptor agonist that raises GH and IGF-1; synthesized by Merck in 1995, discontinued in 1999, never FDA approved, and WADA-prohibited since 2013.
Ibutilide
Ibutilide (ibutilide fumarate, Corvert) is an intravenous class III antiarrhythmic for acute cardioversion of atrial fibrillation and flutter, acting via I_Kr blockade and late sodium current activation, with torsades de pointes as its main risk.
IC50
IC50 (half-maximal inhibitory concentration): concentration inhibiting a biological process by 50% in vitro; distinct from EC50 and Ki, assay-dependent, converted to Ki via Cheng-Prusoff.
Icacinaceae
Icacinaceae Miers (1851), a pantropical family of woody flowering plants in Icacinales; trees, shrubs, and lianas with unilocular ovaries and two pendulous ovules, split from a polyphyletic circumscription into Icacinaceae s.s., Stemonuraceae, Cardiopteridaceae, and Pennantiaceae.
ICAM1
ICAM1 (intercellular adhesion molecule 1, ICAM-1, CD54) is a human gene at 19p13.2 encoding an immunoglobulin-superfamily adhesion glycoprotein that binds LFA-1 and Mac-1, recruits leukocytes in inflammation, serves as rhinovirus receptor, and is a cancer drug target.
ICAM2
ICAM2 (CD102), intercellular adhesion molecule 2, is a human gene at 17q23.3 encoding a two-domain Ig-superfamily transmembrane glycoprotein on endothelium and lymphocytes that binds LFA-1, Mac-1, and DC-SIGN for immune surveillance.
ICAM3
ICAM3, also known as CD50, is a human protein-coding gene whose product sits on all leukocytes and serves as the principal LFA-1 ligand in early T-cell immune responses.
Icaridin
Icaridin (picaridin, Saltidin, KBR 3023) is a synthetic piperidine insect repellent developed by Bayer, similar to DEET in efficacy, sold as 15–20% sprays and lotions, US-registered since 2001/2005.
Icchabhedi rasa
Icchabhedi rasa (Icchābhedi rasa), an Ayurvedic herbo-mineral tablet formulation (AFI000443, 250 mg dose) with mercury, sulphur, borax, black pepper, ginger, and croton seed, used as a purgative in virechana panchakarma therapy.